Blog

The Vie Co. Announces Grand Opening in Cryotherapy Innovation in Los Angeles

 The Vie Co. officially announced the grand opening of their newest state of the art cryotherapy spa…

Alkermes to Take Part in the Goldman Sachs Annual Global Healthcare Conference

Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the Goldman…

Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance

 Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding…

Qazi Cosmetic Clinic Announces Pain-Free MicroLipo™ to Banish Double Chins and Saggy Skin Just in Time for the End of the Pandemic

Spending the past year on Zoom, with its magical retouching and soft-light camera features, has been…

Lung Cancer Research Foundation and EGFR Resisters Announce Partnership

 The Lung Cancer Research Foundation (LCRF) is excited to announce a partnership with leading lung cancer…

Choice Health at Home Announces Multiple Acquisitions in Texas and Oklahoma

Choice Health at Home, LLC (“Choice”) announced today the acquisition of multiple home health and hospice…

Cantel Medical LLC Announces Offer to Purchase Relating to Outstanding Convertible Senior Notes

 Cantel Medical LLC, formerly known as Cantel Medical Corp. (the “Company,” “Cantel,” “we” or “our”), today…

FieldLine Launches HEDscan™, a Next-Generation Device for Non-Invasive Functional Brain Imaging

FieldLine Inc., a biotech company targeting advanced brain diagnostic technology, announced today the general availability of…

Bridge Biotherapeutics Announces the Initiation of the Proof of Mechanism Study for BBT-401 in Patients with Ulcerative Colitis

Bridge Biotherapeutics (KQ288330) today announced the first patient dosing of BBT-401 in its open label, proof…

Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis

Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA)…